About Human Longevity
Human Longevity is a company based in San Diego (United States) founded in 2013 by J Craig Venter and Peter H Diamandis.. Human Longevity has raised $408.72 million across 6 funding rounds from investors including Illumina, General Electric and Synthetic Genomics. Human Longevity has completed 3 acquisitions, including Cypher Genomics, DoctorsForMe.AI and LifebankUSA. Human Longevity operates in a competitive market with competitors including Genomenon, IDbyDNA, Sequentia biotech, Gene Logic and Advaita Bioinformatics, among others.
- Headquarter San Diego, United States
- Founders J Craig Venter, Peter H Diamandis
-
Sectors
Technology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$408.72 M (USD)
in 6 rounds
-
Latest Funding Round
$39.8 M (USD), Series B
Aug 22, 2024
-
Investors
Illumina
& 10 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Cypher Genomics
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Human Longevity
Human Longevity has successfully raised a total of $408.72M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $39.8 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $39.8M
-
First Round
First Round
(04 Mar 2014)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series B - Human Longevity | Valuation | TVM | |
| Mar, 2023 | Amount | Series B - Human Longevity | Valuation |
investors |
|
| Oct, 2022 | Amount | Series B - Human Longevity | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Human Longevity
Human Longevity has secured backing from 11 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Illumina, General Electric and Synthetic Genomics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare growth capital investments are made in transformational companies.
|
Founded Year | Domain | Location | |
|
A life sciences venture fund is operated with global reach.
|
Founded Year | Domain | Location | |
|
Capital is provided to support biomedical industry innovations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Human Longevity
Human Longevity has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cypher Genomics, DoctorsForMe.AI and LifebankUSA. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cancer patients are matched with expert doctors via AI platform.
|
2018 | ||||
|
Cypher Genomics is engaged in genomic diagnostic solutions development.
|
2011 | ||||
|
Full-service stem cell and cord blood storage services are offered.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Human Longevity
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Human Longevity Comparisons
Competitors of Human Longevity
Human Longevity operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genomenon, IDbyDNA, Sequentia biotech, Gene Logic and Advaita Bioinformatics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based bioinformatics tools and genomic variants meta-database are developed.
|
|
| domain | founded_year | HQ Location |
Developer of search engine to identify pathogens in sample
|
|
| domain | founded_year | HQ Location |
Bioinformatics technologies and services are provided by the company.
|
|
| domain | founded_year | HQ Location |
Genomic reference databases and compliant microarray services are provided.
|
|
| domain | founded_year | HQ Location |
Bioinformatics software tools for multi-omics pathway analysis are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Human Longevity
Frequently Asked Questions about Human Longevity
When was Human Longevity founded?
Human Longevity was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Human Longevity located?
Human Longevity is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Human Longevity?
J Craig Venter is the current CEO of Human Longevity. They have also founded this company.
Is Human Longevity a funded company?
Human Longevity is a funded company, having raised a total of $408.72M across 6 funding rounds to date. The company's 1st funding round was a Series B of $6.92M, raised on Mar 04, 2014.
What does Human Longevity do?
Genomics data and cell therapy-based diagnostic and therapeutic solutions. It offers an AI-interfaced platform, enabling a genomics-based technology company to create a database of the whole genome, phenotype, and clinical data. It provides genome sequencing, analysis, and collaboration services for cell therapies and personalized vaccine development. It also offers support services for preventive and personalized care, including cancer analysis, integrated health analysis, newborn screening, and rare, undiagnosed diseases.
Who are the top competitors of Human Longevity?
Human Longevity's top competitors include Genomenon, Sequentia biotech and Gene Logic.
How many acquisitions has Human Longevity made?
Human Longevity has made 3 acquisitions, including Cypher Genomics, DoctorsForMe.AI, and LifebankUSA.
Who are Human Longevity's investors?
Human Longevity has 11 investors. Key investors include Illumina, General Electric, Synthetic Genomics, Celgene, and TVM Capital Healthcare.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.